Latest News

  • 30th December 2024

    Arecor Signs Exclusive Licensing Agreement

  • 18th November 2024

    APPOINTMENT OF INTERIM CHIEF FINANCIAL OFFICER

  • 11th September 2024

    ARECOR PRESENTS POSITIVE DATA FROM PHASE I CLINICAL TRIAL OF AT278 IN LATE-BREAKING ORAL PRESENTATION AT EASD 2024

News

Reset